FDA Device recall Z-0235-2024
Zephyr Endobronchial Valve (EBV) 5.5-LP, REF: EBV-TS-5.5-LP
- FDA Device
- Class II
- ongoing
- Published 2023-11-15
On 2023-11-15 the FDA classified a Class II recall of Zephyr Endobronchial Valve (EBV) 5.5-LP, REF: EBV-TS-5.5-LP by Pulmonx, citing endobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0235-2024 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2023-08-31 |
| Published | 2023-11-15 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Pulmonx |
| Distribution | AR, AZ, CO, FL, IA, IL, MA, MI, NC, NJ, NV, NY, OH, OK, OR, PA, TN, TX, VA, WA, WI, WV |
Product
Zephyr Endobronchial Valve (EBV) 5.5-LP, REF: EBV-TS-5.5-LP
Reason
Endobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024.
Identifiers
| code_info | UDI: (01)00811907030423(10)506590V70(17)241208, Lot: 506590-V7.0 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0235-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.